Journal
DIABETES
Volume 63, Issue 8, Pages 2845-2853Publisher
AMER DIABETES ASSOC
DOI: 10.2337/db13-1652
Keywords
-
Categories
Funding
- Center for Translational Molecular Medicine (CTMM) project PREDICCt (Prediction and Early Diagnosis of Diabetes and Diabetes-related Cardiovascular Complications) [01C-104]
- Dutch Heart Foundation
- Dutch Diabetes Research Foundation
- Dutch Kidney Foundation
- Seventh Framework Programme of the European Community [HEALTH-F2-2009-241544]
- Netherlands Heart Foundation
- Netherlands Scientific Organisation
Ask authors/readers for more resources
Bilirubin, a potent endogenous antioxidant, was found to protect against the development of diabetic nephropathy (DN) in rodents. In humans, cross-sectional studies found an inverse relation between bilirubin and DN. We prospectively investigated whether bilirubin is associated with progression of DN toward end-stage renal disease (ESRD). To this end, we performed a post hoc analysis in the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial with independent replication in the Irbesartan Diabetic Nephropathy Trial (IDNT). Subjects with type 2 diabetes and nephropathy with alanine aminotransferase, aspartate aminotransferase (AST), and bilirubin levels <1.5 times the upper limit of normal were included. The renal end point was defined as the composite of confirmed doubling of serum creatinine or ESRD. Bilirubin was inversely associated with the renal end point in RENAAL independent of age, sex, race, BMI, smoking, total cholesterol, diastolic blood pressure, HbA(1c), treatment, estimated glomerular filtration rate, albumin-to-creatinine ratio, and AST. These results were confirmed in IDNT. This study indicates an independent inverse association of bilirubin with progression of nephropathy in RENAAL and IDNT. These data suggest a protective effect of bilirubin against progression of nephropathy in type 2 diabetes. The well-established role of bilirubin as an antioxidant is a potential explanation for the findings.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available